Symbicort is a prescription drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Learn how to lower long-term costs and more.

Viatris announced the launch of Breyna ™ (budesonide and formoterol fumarate dihydrate) inhalation aerosol, the first generic version of AstraZeneca’s Symbicort ®.. Breyna is a metered-dose ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

There is ongoing patent litigation between AstraZeneca, the maker of Symbicort, and Viatris, formerly known as Mylan Pharmaceuticals, and its drug delivery device partner Kindeva Drug Delivery LP.

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort.

Symbicort uses the corticosteroid budesonide, while Advair contains fluticasone. The long-acting beta 2 -adrenergic agonist in either drug helps relax the muscles around the airways in your lungs.

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort. S&P 500 +---% | Stock Advisor +---% Join The Motley Fool ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...